Journal rankings · indicator year 2021
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2021
Pulmonary and Respiratory Medicine journal rankings 2021
362 ranked journals · Subfield in Medicine
Pulmonary and Respiratory Medicine has 362 ranked journals in 2021. The median OJR fell 0.06 on 2020 to 0.67, below the world average of 1.00; Q1 starts at OJR 1.06. The top three are The Lancet Respiratory Medicine, European Urology, and Intensive Care Medicine.
Ranks and citation indicators: 2021. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2018–2020, the window the 2021 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery985
- Pulmonary and Respiratory Medicine362
- Public Health, Environmental and Occupational Health303
- Cardiology and Cardiovascular Medicine297
- Oncology239
- Infectious Diseases234
- Epidemiology204
- Neurology172
- Radiology, Nuclear Medicine and Imaging170
- Endocrinology, Diabetes and Metabolism163
- Physiology163
- Psychiatry and Mental health145
Show all 42 subfields
- Orthopedics and Sports Medicine124
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology99
- Hematology83
- Obstetrics and Gynecology83
- Rheumatology67
- Nephrology61
- Pharmacology54
- Complementary and alternative medicine50
- Reproductive Medicine49
- Emergency Medicine45
- Geriatrics and Gerontology39
- Rehabilitation37
- Otorhinolaryngology35
- Hepatology29
- Pathology and Forensic Medicine26
- Critical Care and Intensive Care Medicine24
- Immunology and Allergy23
- Genetics20
- Anesthesiology and Pain Medicine14
- Urology14
- Gastroenterology6
- Health Informatics5
- Internal Medicine5
- Transplantation3
- Family Practice2
- Biochemistry1
- Anatomy0
- Microbiology0
362 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2020. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2018–2020, the window the 2021 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2018–2020 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2012 to 2021. | Compare |
|---|---|---|---|---|---|---|---|
1The Lancet Respiratory MedicineElsevier BV · Netherlands | 7.46Q1 | 42.78 29.58 up from 2020 | 633 | 78% | $7,280 | ||
2European UrologyElsevier BV · Switzerland | 4.45Q1 | 14.81 1.57 up from 2020 | 804 | 14% | $5,250 | ||
3Intensive Care MedicineSpringer Science+Business Media · Germany | 3.74Q1 | 17.43 10.68 up from 2020 | 1,037 | 77% | $5,190 | ||
4DrugsAdis, Springer Healthcare · New Zealand | 3.33Q1 | 13.10 2.11 up from 2020 | 494 | 58% | $5,990 | ||
5Cochrane Database of Systematic ReviewsElsevier BV · United Kingdom | 3.18Q1 | 9.27 0.80 up from 2020 | 2,709 | 82% | $5,100 | ||
6European Respiratory ReviewOAEuropean Respiratory Society · United Kingdom | 3.07Q1 | 10.90 0.57 up from 2020 | 223 | 100% | — | ||
7European Respiratory JournalEuropean Respiratory Society | 2.82Q1 | 12.42 4.19 up from 2020 | 1,860 | 96% | — | ||
8American Journal of Respiratory and Critical Care MedicineAmerican Thoracic Society · United States | 2.77Q1 | 10.46 2.37 up from 2020 | 1,833 | 80% | — | ||
9Annals of Intensive CareOASpringer Nature · France | 2.61Q1 | 10.45 2.53 up from 2020 | 426 | 100% | $3,490 | ||
10Modern PathologyElsevier BV · United States | 2.60Q1 | 9.37 1.58 up from 2020 | 652 | 95% | $4,480 | ||
11Critical CareOABioMed Central · United Kingdom | 2.56Q1 | 12.75 5.01 up from 2020 | 1,463 | 100% | $4,190 | ||
12Journal of Thoracic OncologyElsevier BV · United States | 2.40Q1 | 9.13 1.42 up from 2020 | 1,018 | 100% | $4,100 | ||
13Gastric CancerSpringer Science+Business Media · Japan | 2.22Q1 | 7.91 1.06 up from 2020 | 336 | 97% | $3,590 | ||
14The Journal of UrologyLippincott Williams & Wilkins · United States | 2.20Q1 | 6.11 0.05 down from 2020 | 428 | 11% | $3,000 | ||
15Seminars in Fetal and Neonatal MedicineElsevier BV · Netherlands | 2.12Q1 | 4.25 0.10 down from 2020 | 171 | 34% | $4,590 | ||
16Drugs in ContextOABioExcel Publishing Ltd · United Kingdom | 2.07Q1 | 6.20 1.32 down from 2020 | 167 | 100% | $1,901 | ||
17Respiratory ResearchOABioMed Central · United Kingdom | 2.01Q1 | 8.22 1.70 up from 2020 | 870 | 100% | $3,490 | ||
18Advances in UrologyOAHindawi Publishing Corporation · United Kingdom | 1.99Q1 | 1.90 2.64 down from 2020 | 48 | 100% | $1,000 | ||
19ThoraxBMJ · United Kingdom | 1.95Q1 | 7.70 2.20 up from 2020 | 608 | 65% | — | ||
20Journal of Photochemistry and Photobiology B BiologyElsevier BV · Netherlands | 1.90Q1 | 6.90 0.23 up from 2020 | 849 | 31% | $4,110 | ||
21European Urology OncologyElsevier BV · Netherlands | 1.83Q1 | 6.03 0.34 up from 2020 | 357 | 31% | $3,790 | ||
22HistopathologyWiley · United Kingdom | 1.82Q1 | 7.06 2.12 up from 2020 | 690 | 36% | $4,840 | ||
23Seminars in PerinatologyElsevier BV · United States | 1.79Q1 | 3.91 0.10 up from 2020 | 231 | 28% | $4,370 | ||
24Radiotherapy and OncologyElsevier BV · Netherlands | 1.78Q1 | 5.89 0.05 up from 2020 | 1,239 | 10% | $3,770 | ||
25Cancer ImagingOABioMed Central · United Kingdom | 1.73Q1 | 6.19 1.50 up from 2020 | 231 | 100% | $2,790 | ||
26Clinics in Chest MedicineElsevier BV · United States | 1.72Q1 | 5.97 2.22 up from 2020 | 190 | 17% | $3,350 | ||
27Therapeutic Advances in Chronic DiseaseOASAGE Publishing · United Kingdom | 1.71Q1 | 5.35 0.65 down from 2020 | 157 | 100% | $2,950 | ||
28Archives of Disease in Childhood Fetal & NeonatalBMJ · United Kingdom | 1.68Q1 | 4.67 0.72 up from 2020 | 408 | 43% | — | ||
29Advances in Anatomic PathologyLippincott Williams & Wilkins · United States | 1.68Q1 | 4.96 0.69 up from 2020 | 106 | 13% | — | ||
30BMJ Open Respiratory ResearchOABMJ · United Kingdom | 1.60Q1 | 6.47 1.77 up from 2020 | 250 | 100% | $2,085 | ||
31Gastrointestinal EndoscopyElsevier BV · United States | 1.59Q1 | 5.26 0.28 down from 2020 | 1,266 | 22% | $3,450 | ||
32NeonatologyKarger Publishers · Switzerland | 1.59Q1 | 4.72 0.60 up from 2020 | 298 | 52% | — | ||
33Clinical and Translational Radiation OncologyOAElsevier BV · Ireland | 1.55Q1 | 4.81 0.12 down from 2020 | 247 | 100% | $2,430 | ||
34British Journal of UrologyWiley · United Kingdom | 1.55Q1 | 4.66 0.42 up from 2020 | 913 | 44% | $4,770 | ||
35Current Opinion in Critical CareLippincott Williams & Wilkins · United States | 1.53Q1 | 3.80 0.63 down from 2020 | 279 | 42% | — | ||
36Lung CancerElsevier BV · Netherlands | 1.53Q1 | 5.71 0.25 up from 2020 | 996 | 31% | $3,390 | ||
37Prostate Cancer and Prostatic DiseasesSpringer Nature · United Kingdom | 1.52Q1 | 5.25 0.24 up from 2020 | 269 | 64% | $5,190 | ||
38Therapeutic Advances in Respiratory DiseaseOASAGE Publishing · United States | 1.50Q1 | 5.84 0.59 up from 2020 | 188 | 100% | $2,650 | ||
39Annals of the American Thoracic SocietyAmerican Thoracic Society · United States | 1.45Q1 | 5.01 0.63 up from 2020 | 862 | 68% | — | ||
40Frontiers in MedicineOAFrontiers Media · Switzerland | 1.45Q1 | 6.23 0.08 down from 2020 | 1,645 | 100% | $3,801 | ||
41CHEST JournalElsevier BV · United States | 1.44Q1 | 4.64 0.45 up from 2020 | 2,299 | 75% | $4,160 | ||
42European Urology FocusElsevier BV · Netherlands | 1.43Q1 | 4.66 0.85 up from 2020 | 564 | 41% | $3,800 | ||
43International Journal of Radiation Oncology*Biology*PhysicsElsevier BV · United States | 1.43Q1 | 4.71 0.14 up from 2020 | 1,671 | 67% | $4,130 | ||
44Journal of Cystic FibrosisElsevier BV · Netherlands | 1.42Q1 | 4.86 0.22 up from 2020 | 541 | 100% | $4,370 | ||
45Advances in TherapyAdis, Springer Healthcare · United Kingdom | 1.42Q1 | 4.61 0.40 up from 2020 | 867 | 74% | $4,790 | ||
46American Journal of Physiology-Lung Cellular and Molecular PhysiologyAmerican Physical Society · United States | 1.41Q1 | 5.71 0.66 up from 2020 | 601 | 74% | — | ||
46Seminars in Respiratory and Critical Care MedicineThieme Medical Publishers (Germany) · United States | 1.41Q1 | 4.58 0.50 up from 2020 | 223 | 14% | — | ||
48Occupational and Environmental MedicineBMJ · United Kingdom | 1.40Q1 | 4.77 0.94 up from 2020 | 454 | 64% | — | ||
49Medical SciencesOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.38Q1 | 4.23 0.63 down from 2020 | 271 | 100% | $1,689 | ||
50Therapeutic Advances in UrologyOASAGE Publishing · United Kingdom | 1.37Q1 | 3.94 0.53 up from 2020 | 131 | 100% | $2,650 |
Subfields of Medicine, with Pulmonary and Respiratory Medicine highlighted.
- Surgery985
- Pulmonary and Respiratory Medicine362
- Public Health, Environmental and Occupational Health303
- Cardiology and Cardiovascular Medicine297
- Oncology239
- Infectious Diseases234
- Epidemiology204
- Neurology172
- Radiology, Nuclear Medicine and Imaging170
- Endocrinology, Diabetes and Metabolism163
- Physiology163
- Psychiatry and Mental health145
- Orthopedics and Sports Medicine124
- Ophthalmology103
- Pediatrics, Perinatology and Child Health101
- Dermatology99
- Hematology83
- Obstetrics and Gynecology83
- Rheumatology67
- Nephrology61
- Pharmacology54
- Complementary and alternative medicine50
- Reproductive Medicine49
- Emergency Medicine45
- Geriatrics and Gerontology39
- Rehabilitation37
- Otorhinolaryngology35
- Hepatology29
- Pathology and Forensic Medicine26
- Critical Care and Intensive Care Medicine24
- Immunology and Allergy23
- Genetics20
- Anesthesiology and Pain Medicine14
- Urology14
- Gastroenterology6
- Health Informatics5
- Internal Medicine5
- Transplantation3
- Family Practice2
- Biochemistry1
- Anatomy0
- Microbiology0
Journals
Citations made in 2021. Corpus-wide, 87.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
98 additional Pulmonary and Respiratory Medicine journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2018–2020, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2021. Publication window: 2018–2020. How these summaries are calculated
- Ranked journals
- 362
- Window papers (baseline)
- 189,625 +15.5% from indicator year 2018
- Median OJR
- 0.6663 -1.5% from indicator year 2018
- Rising journals (2025)
- 26
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2018–2020 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 116 | 128 | 133 | 140 | 152 | 172 | 181 | 194 | 199 | 212 | 221 | 236 | 245 | 266 | 283 | 297 | 315 | 324 | 349 | 347 | 353 | 362 | 367 | 367 | 364 | 352 | |
| Window papers (baseline) | 51,191 | 58,101 | 61,730 | 66,053 | 67,282 | 74,504 | 82,746 | 93,558 | 102,120 | 113,728 | 123,057 | 131,093 | 135,018 | 138,763 | 146,389 | 152,077 | 157,160 | 158,971 | 164,168 | 168,770 | 175,931 | 189,625 | 206,647 | 218,275 | 218,995 | 219,470 | |
| Median OJR | 0.56 | 0.57 | 0.55 | 0.628 | 0.671 | 0.663 | 0.713 | 0.664 | 0.693 | 0.70 | 0.767 | 0.80 | 0.84 | 0.768 | 0.75 | 0.731 | 0.689 | 0.6662 | 0.68 | 0.710 | 0.730 | 0.6663 | 0.665 | 0.687 | 0.64 | 0.633 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.